Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyue Deng

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Autophagy|September 9, 2025
Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancerNan Huang, Junxi Ren, Xinyue Deng, et al.
Frontiers in Oncology|June 27, 2022
Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035Yizhen Li, Jinxin Zheng, Yujiao Deng, et al.
Frontiers in Public Health|December 10, 2021
Global Burden of Respiratory Diseases Attributable to Ambient Particulate Matter Pollution: Findings From the Global Burden of Disease Study 2019Ying Wu, Ping Song, Shuai Lin, et al.
Nature Communications|December 2, 2025
Residual tumor cells after insufficient radiofrequency ablation promote lung metastasis by educating CD177<sup>hi</sup>PAD4<sup>hi</sup> neutrophilsNa Huang, Yisheng Fang, Siting Zheng, et al.
Nature Communications|January 26, 2026
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in miceJinshan Nan, Huiping Shuai, Jingxin Qiao, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 12, 2025
Community-engaged efforts to increase retention of Black American online registry participantsMiriam T Ashford, Anna Aaronson, Danqi Zhu, et al.
Research Square|November 28, 2024
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHin Chu, Huiping Shuai, Jingxin Qiao, et al.
Nature Communications|December 15, 2025
Author Correction: An orally available M<sup>pro</sup>/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Jingxin Qiao, Chaemin Yoon, et al.
Nature Communications|July 16, 2025
An orally available M<sup>pro</sup>/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Jingxin Qiao, Chaemin Yoon, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Autophagy|September 9, 2025
Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancerNan Huang, Junxi Ren, Xinyue Deng, et al.
Frontiers in Oncology|June 27, 2022
Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035Yizhen Li, Jinxin Zheng, Yujiao Deng, et al.
Frontiers in Public Health|December 10, 2021
Global Burden of Respiratory Diseases Attributable to Ambient Particulate Matter Pollution: Findings From the Global Burden of Disease Study 2019Ying Wu, Ping Song, Shuai Lin, et al.
Nature Communications|December 2, 2025
Residual tumor cells after insufficient radiofrequency ablation promote lung metastasis by educating CD177<sup>hi</sup>PAD4<sup>hi</sup> neutrophilsNa Huang, Yisheng Fang, Siting Zheng, et al.
Nature Communications|January 26, 2026
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in miceJinshan Nan, Huiping Shuai, Jingxin Qiao, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 12, 2025
Community-engaged efforts to increase retention of Black American online registry participantsMiriam T Ashford, Anna Aaronson, Danqi Zhu, et al.
Research Square|November 28, 2024
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHin Chu, Huiping Shuai, Jingxin Qiao, et al.
Nature Communications|December 15, 2025
Author Correction: An orally available M<sup>pro</sup>/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Jingxin Qiao, Chaemin Yoon, et al.
Nature Communications|July 16, 2025
An orally available M<sup>pro</sup>/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Jingxin Qiao, Chaemin Yoon, et al.
Pageof 8